ArticleJournal of experimental & clinical cancer research : CR2024

Inhibition of the chemokine receptors CXCR1 and CXCR2 synergizes with docetaxel for effective tumor control and remodeling of the immune microenvironment of HPV-negative head and neck cancer models.

Lucas A Horn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.